ilShinBioBase Co

ilShinBioBase Co Equity

The The Equity of ilShinBioBase Co (068330.KQ) as of Sep 28, 2026 is 64.80 B KRW. In the previous year, The Equity was 60.45 B KRW — a change of 7.19% (higher).

Equity

64.80 BKRW

YoY

7.19%

Last updated:

In 2026, ilShinBioBase Co's equity was 64.80 B KRW, a 7.19% increase from the 60.45 B KRW equity in the previous year.

The ilShinBioBase Co Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
35.72 B KRW
Jan 1, 2019
40.16 B KRW
Jan 1, 2020
44.38 B KRW
Jan 1, 2021
50.47 B KRW
Jan 1, 2022
53.82 B KRW
Jan 1, 2023
57.06 B KRW
Jan 1, 2024
60.45 B KRW
Jan 1, 2025
64.80 B KRW
The ilShinBioBase Co Equity history
YEAREquityYoY
64.80 BKRW+7.19%
60.45 BKRW+5.93%
57.06 BKRW+6.03%
53.82 BKRW+6.64%
50.47 BKRW+13.72%
44.38 BKRW+10.51%
40.16 BKRW+12.44%
35.72 BKRW+1.41%
35.22 BKRW+6.78%
32.98 BKRW+35.71%
24.30 BKRW+0.39%
24.21 BKRW—
Access this data via the Eulerpool API
Get Free API Key

ilShinBioBase Co Stock analysis

What does ilShinBioBase Co do? ilShinBioBase Co is one of the most popular companies on Eulerpool.

Equity Details

Analyzing ilShinBioBase Co's Equity

ilShinBioBase Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding ilShinBioBase Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating ilShinBioBase Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

ilShinBioBase Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in ilShinBioBase Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about ilShinBioBase Co stock

The Equity of ilShinBioBase Co is 64.80 B KRW in 2026.

The Equity of ilShinBioBase Co changed from 60.45 B KRW to 64.80 B KRW, representing a 7.19% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity ilShinBioBase Co since 2006 – with annual values, charts, and detailed analysis.

The Equity's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's ilShinBioBase Co historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — ilShinBioBase Co

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — ilShinBioBase Co